An Open-Label, Multi-Cetre, Phase II Study Evaluating the Safety and Efficacy of 323U66 SR in Patients With Depression
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Bupropion (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual start date changed from Jan 2005 to Dec 2004 as reported by Clinicaltrials.gov.
- 15 Nov 2007 Status changed from in progress to completed.
- 02 Sep 2006 New trial record.